胶质瘤患者队列中人类白细胞抗原多样性的免疫流行病学图谱
该研究利用4个大型胶质瘤队列及健康队列的测序数据,在按祖先匹配、按种族和年龄匹配的Hardy-Weinberg平衡推算队列中,识别HLA-I等位基因,用逻辑回归估计发病比值比、Cox回归量化预后。分析了1215例非西班牙裔白人和亚洲胶质瘤患者,发现特定HLA-I等位基因与胶质瘤发病和预后显著相关且存在种族差异,非西班牙裔白人胶质瘤患者HLA纯合率高于种族匹配对照。
要点
- 特定HLA-I等位基因与胶质瘤发病和预后显著相关,效应存在种族差异,且独立于年龄和性别。
- 非西班牙裔白人胶质瘤患者的HLA纯合率高于种族匹配对照。
- HLA-C01:02与HLA-C07:02在不同种族间对胶质瘤预后的作用方向相反。
核心结论
- 特定HLA-I等位基因的表达与种族内胶质瘤发病和预后相关。
- HLA-I纯合是非西班牙裔白人胶质瘤的危险因素。
- 这些发现可能指导胶质瘤精准免疫治疗的开发。
研究设计与样本
- 利用4个大型胶质瘤队列和健康队列的测序数据识别HLA-I等位基因,按祖先匹配,并采用Hardy-Weinberg平衡推算的按种族和年龄匹配队列。
- 发病比值比通过逻辑回归估计,HLA预后通过Cox回归量化。
- 分析了1215例非西班牙裔白人和亚洲胶质瘤患者。
主要发现
- 胶质瘤的HLA-I等位基因频率总体与各 race 内的分布一致。
- 特定HLA-I等位基因与胶质瘤发病和预后显著相关,种族间不同,但独立于年龄和性别。
- 非西班牙裔白人胶质瘤患者HLA纯合率高于种族匹配对照。
- HLA-C01:02和HLA-C07:02在不同种族间对胶质瘤预后显示相反作用。
- 上述不同作用与其呈递胶质瘤进展初期或晚期出现的特定突变的能力相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individual-level characteristics underlying population-level variation in glioma risk and outcomes remain incompletely understood. Cancer immunosurveillance, host immunity, and some immunotherapies center on the ability of an individual's immune cells to recognize antigen epitopes presented on major histocompatibility complex molecules. Inter-individual variation in human leukocyte antigen (HLA) alleles can elicit distinct repertoires of tumor antigen for presentation to immune cells. Therefore, HLA alleles may impact glioma incidence and prognosis. METHODS: HLA class I (HLA-I) alleles were identified using sequencing data from 4 large glioma cohorts and healthy cohorts, matched on ancestry, and race- and age-matched imputed cohorts developed by the Hardy-Weinberg equilibrium were referred to determine odds ratio incidence estimated by logistic regression. HLA prognostication was quantified by Cox regression. RESULTS: We analyzed 1215 cases of glioma patients from non-Hispanic Whites and Asians. The HLA-I allelic frequencies of gliomas generally corresponded to their distribution within each race. However, specific HLA-I alleles were significantly associated with glioma incidence and prognosis, which differ between races but were independent of age and sex. Notably, non-Hispanic White glioma patients exhibited greater HLA homozygosity rates compared with race-matched controls. HLA-C01:02 and HLA-C07:02 displayed opposing effects on glioma prognosis between races. The distinct effects were associated with their capability of presenting specific mutations that appeared at the initial or late phase of glioma progression. CONCLUSIONS: Expression of specific HLA-I alleles are associated with glioma incidence and prognosis within race. HLA-I-homozygosity is a risk factor for glioma in non-Hispanic Whites. These findings may guide the development of precision-guided immunotherapies for glioma.
引用
- Xiong Z, Walsh KM, Sneiderman CT, et al. Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts. Neuro Oncol. 2025. PMID: 39949048. doi:10.1093/neuonc/noaf040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。